Current Cancer Therapy Reviews
Title:Meet Our Editorial Board Member
Volume: 13 Issue: 2
Author(s): Jing Cai
Affiliation:
Export Options
About this article
Cite this article as:
Cai Jing , Meet Our Editorial Board Member, Current Cancer Therapy Reviews 2017; 13 (2) . https://dx.doi.org/10.2174/157339471302171115152024
DOI https://dx.doi.org/10.2174/157339471302171115152024 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting Cytokines for Morphine Tolerance: A Narrative Review
Current Neuropharmacology Recent Developments in Tumor Angiogenesis
Current Pharmaceutical Biotechnology Herpesvirus Saimiri-Based Gene Delivery Vectors
Current Gene Therapy The Plant-Type Ferredoxin-NADP+ Reductase/Ferredoxin Redox System as a Possible Drug Target Against Apicomplexan Human Parasites
Current Pharmaceutical Design QSAR and Docking Studies on Piperidyl-cyclohexylurea Derivatives for Prediction of Selective and Potent Inhibitor of Matriptase
Current Computer-Aided Drug Design Structure-Based Design of Novel Anticancer Agents
Current Cancer Drug Targets Predicting Toxicity: Biomarkers and the Value of the Patient's Opinion
Current Pharmaceutical Design Immunomodulatory and Anti-Inflammatory Activities of Statins
Endocrine, Metabolic & Immune Disorders - Drug Targets Editorial (Thematic Issue: Contemporary siRNA Therapeutics and the Current State-of-Art)
Current Pharmaceutical Design Rheumatology: A Force for Change in Monoclonal Antibodies
Current Pharmaceutical Design Drug Therapy of Neuropathic Pain: Current Developments and Future Perspectives
Current Drug Targets Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases
Current Medicinal Chemistry The Interactions of Anti-Cancer Drugs Approved in the Last Decade in the United States with Membrane Transporters
Anti-Cancer Agents in Medicinal Chemistry Molecular Profiles of Sentinel and Non-Sentinel Lymph Nodes in Breast Cancer Progression and Prognosis
Current Cancer Therapy Reviews The Antioxidants and Pro-Antioxidants Network: An Overview
Current Pharmaceutical Design Advances in Chemotherapy and Targeted Systemic Therapies for Urothelial Cancer
Current Drug Therapy Melatonin: Pharmacology, Functions and Therapeutic Benefits
Current Neuropharmacology Patents on Non-Viral Mediated Gene Delivery
Recent Patents on DNA & Gene Sequences Novel Ligands: Fine Tuning the Transcriptional Activity of the Glucocorticoid Receptor
Current Pharmaceutical Design Protein Cysteine Modifications: (2) Reactivity Specificity and Topics of Medicinal Chemistry and Protein Engineering
Current Medicinal Chemistry